Literature DB >> 27355693

Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy.

Charumathi Sabanayagam1,2,3, WanFen Yip1, Daniel S W Ting1, Gavin Tan1, Tien Y Wong1,3,4.   

Abstract

PURPOSE: Diabetes is a major public health problem affecting 415 million people worldwide. With the increasing prevalence of diabetes, diabetic retinopathy (DR) is emerging as the leading cause of avoidable blindness worldwide.
METHODS: We reviewed previous and recent literature to provide an overview of emerging trends on the burden, epidemiology, risk factors, and prevention of DR.
RESULTS: First, there is clear evidence of a global increase in the prevalence of diabetes. Second, there is a decline in the incidence of blindness due to DR, particularly in developed countries. Third, diabetic macular edema (DME) rather than proliferative diabetic retinopathy (PDR) is the increasingly common cause of visual impairment. Fourth, DR awareness remains patchy and low in most populations. Fifth, hyperglycemia remains the most consistent risk factor for DR in type 1 diabetes across different studies and populations. Sixth, in contrast, blood pressure is an important risk factor for DR in type 2 diabetes. Seventh, the relationship between dyslipidemia and DR remains unclear, with inconsistent results from different studies and trials. Eighth, the utility of predictive models incorporating multiple risk factors for assessing DR risk requires evaluation. Ninth, photographic screening of DR using tele-ophthalmology platforms is increasingly recognized as being feasible and cost-effective. Finally, DR prevention in low-resource settings cannot follow models developed in high-resource countries and requires different strategies.
CONCLUSIONS: The ten trends we observed in the current review may guide planning of public healthcare strategies for the management of DR and prevention of blindness.

Entities:  

Keywords:  Awareness; burden; diabetic retinopathy; prevention; risk factors

Mesh:

Year:  2016        PMID: 27355693     DOI: 10.1080/09286586.2016.1193618

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  32 in total

1.  Five-Year Cost-Effectiveness Modeling of Primary Care-Based, Nonmydriatic Automated Retinal Image Analysis Screening Among Low-Income Patients With Diabetes.

Authors:  Spencer D Fuller; Jenny Hu; James C Liu; Ella Gibson; Martin Gregory; Jessica Kuo; Rithwick Rajagopal
Journal:  J Diabetes Sci Technol       Date:  2020-10-30

2.  Diabetic retinopathy in Greece: prevalence and risk factors studied in the medical retina clinic of a Greek tertiary hospital.

Authors:  Maria Syriga; Zina Ioannou; Christos Pitsas; Ioanna Dagalaki; Michael Karampelas
Journal:  Int Ophthalmol       Date:  2022-01-31       Impact factor: 2.031

3.  Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.

Authors:  Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

Review 4.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

Review 5.  Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.

Authors:  Osinakachukwu Mbata; Nada Fawzy Abo El-Magd; Azza Bahram El-Remessy
Journal:  World J Diabetes       Date:  2017-07-15

6.  Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.

Authors:  Benedetta Maria Bonora; Mattia Albiero; Mario Luca Morieri; Roberta Cappellari; Francesco Ivan Amendolagine; Marta Mazzucato; Alberto Zambon; Elisabetta Iori; Angelo Avogaro; Gian Paolo Fadini
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

Review 7.  EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress.

Authors:  Roberta Giordo; Yusra M A Ahmed; Hilda Allam; Salah Abusnana; Lucia Pappalardo; Gheyath K Nasrallah; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Front Cell Dev Biol       Date:  2021-05-19

8.  Learning curve evaluation upskilling retinal imaging using smartphones.

Authors:  Linus G Jansen; Payal Shah; Bettina Wabbels; Frank G Holz; Robert P Finger; Maximilian W M Wintergerst
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

9.  Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort.

Authors:  Lazaros Konstantinidis; Tania Carron; Eva de Ancos; Léonie Chinet; Isabelle Hagon-Traub; Emilie Zuercher; Isabelle Peytremann-Bridevaux
Journal:  BMC Endocr Disord       Date:  2017-09-07       Impact factor: 2.763

10.  Associations with sight-threatening diabetic macular oedema among Indigenous adults with type 2 diabetes attending an Indigenous primary care clinic in remote Australia: a Centre of Research Excellence in Diabetic Retinopathy and Telehealth Eye and Associated Medical Services Network study.

Authors:  Laima Brazionis; Anthony Keech; Christopher Ryan; Alex Brown; David O'Neal; John Boffa; Sven-Erik Bursell; Alicia Jenkins
Journal:  BMJ Open Ophthalmol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.